Small Pharma to participate in the 34th Annual Roth Conference

Presentation to be webcast on Monday, March 14 at 3:30 – 3:55PM/PT

Small Pharma is pleased to announce its participation at the 34th Annual Roth Conference 2022.

A fireside chat will be hosted by a banking analyst from Roth in discussion with Small Pharma’s CEO, Peter Rands and Chief Medical and Scientific Officer, Dr. Carol Routledge. Small Pharma will also take part in a panel discussion, Psychedelics: “Immunotherapy” for the Mind. Both will be available by live webcast via the links below.

Details for the fireside chat and panel session are as follows:

Fireside Chat  

Presenters: Peter Rands, CEO and Dr Carol Routledge, Chief Medical and Science Officer 

When: Monday, March 14 from 3.30PM – 3.55PM / PT

Webcast Link Registration: Fireside Chat

Panel Discussion 

When: Tuesday, March 15 from 10AM / PT

Webcast Link Registration: Panel – Psychedelics: Immunotherapy for the Mind

Meeting Availability

To schedule a one-on-one meeting with the Small Pharma’s management team, please contact your Roth representative directly, or email 

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: